Nancy Stuart
2020
In 2020, Nancy Stuart earned a total compensation of $1.6M as Chief Operating Officer at Concert Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $177,812 |
|---|---|
| Option Awards | $455,212 |
| Salary | $444,530 |
| Stock Awards | $493,096 |
| Other | $12,114 |
| Total | $1,582,764 |
Stuart received $493.1K in stock awards, accounting for 31% of the total pay in 2020.
Stuart also received $177.8K in non-equity incentive plan, $455.2K in option awards, $444.5K in salary and $12.1K in other compensation.
Rankings
In 2020, Nancy Stuart's compensation ranked 6,601st out of 13,090 executives tracked by ExecPay. In other words, Stuart earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,601 out of 13,090 | 50th |
Division Manufacturing | 2,738 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,104 out of 2,254 | 51st |
Industry group Drugs | 957 out of 1,954 | 51st |
Industry Pharmaceutical Preparations | 716 out of 1,459 | 51st |
Source: SEC filing on April 27, 2021.
Stuart's colleagues
We found two more compensation records of executives who worked with Nancy Stuart at Concert Pharmaceuticals in 2020.